NIH-funded research Sbir 2 grant

An electrical device to relieve pain after surgery without drugs

Official title: An Electrical Neurostimulation Device for Drug-Free, Long-Term Treatment of Post-Operative Pain

Funded at Synaptrix INC · NIH-11408281 · Data updated 2026-11-12

A new non-drug, non-invasive neuromodulation device called NOVABLOC aims to reduce post-operative pain and support rehab by blocking pain signals without affecting movement.

More Post Operative Pain research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionSynaptrix INC
NIH-funded
Lab location1 site (Alpharetta, United States)
Project startSeptember 22, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$920,044
NIH project number1R44AR087332-01A1
Project IDNIH-11408281 on NIH RePORTER

Who could benefit from this research

Could help

Patients undergoing surgery who experience acute post-operative pain and are seeking non-drug pain management options.

Less likely to help

Patients who do not require post-operative pain management or have contraindications to neuromodulation may have limited benefit.

What this research studies

This grant supports developing and bringing NOVABLOC to market as a non-addictive, drug-free option for managing pain after surgery. The device uses a high-frequency stimulation to temporarily block pain signals from nerves while preserving motor function, enabling patients to participate in physical therapy. Researchers will focus on refining the technology, ensuring safety, and preparing for clinical use with healthcare providers. The goal is to offer patients an effective alternative to opioids that can improve recovery and reduce opioid-related risks.

Why it matters

Potential benefit: If successful, patients could experience better pain control after surgery without opioids, improving recovery and reducing side effects.

How similar studies have gone: Other neuromodulation approaches have shown promise for pain relief, but this specific high-frequency, selective conduction-block technology is novel.

Where this research is happening

  • Synaptrix INC
    Alpharetta, United States
    Active

Researchers

  • Principal investigator: Schepis, Eric Anthony — Synaptrix INC
  • Study coordinator: Schepis, Eric Anthony

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.